News

Filter

Current filters:

LucentisDiabetes

Safety of Novartis' Lucentis in VI-DME confirmed with new data; efficacy in CNV

06-09-2012

New data revealed yesterday by Swiss drug major Novartis (NOVN: VX) showed that Lucentis (ranibizumab)…

DiabetesLucentisNovartisOphthalmicsPharmaceuticalRegulationResearchRoche

Drug approval and launch for Novartis in China, where Quintiles expands

18-01-2012

Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

Novartis’ ranibizumab significantly more effective than standard of care in treating vision loss due to diabetes complication DME

24-05-2010

Swiss drug major Novartis says that the first results of the RESTORE Phase III study show that ranibizumab…

DiabetesLucentisNovartisOphthalmicsPharmaceuticalResearch

Back to top